Results for "Understanding Pharmaceutical Distribution"
HDA Research Foundation Explores Challenges and Opportunities of Cold Chain Product Distribution
A new publication released by the HDA Research Foundation and Envision Pharma Group — The Future of the U.S. Pharmaceutical Cold Chain — offers strategies to address the remarkable growth of temperature-sensitive products in the healthcare ecosystem — a product class that, as noted in the report, has outpaced non-cold chain therapies by 21 percent between 2018 and 2024.
HDA Unveils Redesigned HDA.org
The Healthcare Distribution Alliance (HDA) today launched a next-generation website, located at HDA.org. The website features a bright, contemporary design and intuitive functionality with member database integration and a resource-rich “Industry Hub.”
Kaminsky and Hatcher To Lead HDA Board of Directors; Syvinski Appointed to Executive Committee
The Healthcare Distribution Alliance (HDA) announced Kirk Kaminsky and Jody Hatcher will serve a second year as Chairman and Vice Chairman, respectively, of the HDA Board of Directors.
Specialty Distributors Continue To Provide Effective Delivery and Value to the U.S. Healthcare Ecosystem
New benchmarking data released by the HDA Research Foundation showcase the continued value of HDA specialty distributors to the U.S. healthcare ecosystem. As illustrated in the 15th edition of Specialty Pharmaceutical Distribution Facts Figures and Trends, the average specialty distributor delivered medicines to treat chronic, complex or rare diseases to 51,469 unique ship-to points in 2022.